Women's Hospital School of Medicine Zhejiang University
Women's Hospital School of Medicine Zhejiang University
Hangzhou, China4 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Modified Diagnosis and Treatment of Neonatal Hemolysis With ETCOc in sNH | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hyperbilirubinemia, Neonatal, Infant, Newborn, Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, hyperbilirubinemia | Recruiting | Early phase 1 | 2026-01-20 | NCT06832800 | |
| A Study of AK104 Plus Platinum-containing Chemotherapy±Bevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical Cancer | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, cervix disorder, female reproductive system disorder, female reproductive system neoplasm, neoplasm, uterine disorder | Active, not recruiting | Phase 3 | 2025-11-19 | NCT04982237 | |
| PREvention of Intrauterine Adhesion After Adhesiolysis With Novel Tri-block deGradable Polymer Film. | Asherman syndrome, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Urogenital Diseases, female reproductive system disorder, gynatresia, infertility disorder | Active, not recruiting | Not applicable | 2025-03-27 | NCT04963179 | |
| Clinical Value of ETCOc in the Diagnosis and Treatment of ABO-HDN | Pathologic Processes, Pathological Conditions, Signs and Symptoms, hyperbilirubinemia | Recruiting | Not stated | 2025-02-05 | NCT05842109 |